Antistaphyloccal activity of the novel cephalosporin CB-181963 (CAB-175)

Journal of Antimicrobial Chemotherapy

Volumn 55, Issue 4, 2005, Pages 579-582

  Miller, Keith ^a   Storey, Christopher ^a,b   Stubbings, William J ^a   Hoyle, Anthony M ^a   Hobbs, Joanne K ^a   Chopra, Ian ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Methicillin resistance Staphylococcus aureus; Penicillin binding proteins

Indexed keywords

BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CAB 175; CB 181963; CEPHALOSPORIN; CEPHALOSPORIN DERIVATIVE; HISTONE H3; METICILLIN; NEW DRUG; PENICILLIN BINDING PROTEIN; PENICILLIN BINDING PROTEIN 2A; PENICILLIN G; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; CARRIER PROTEIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM MUTANT; BINDING AFFINITY; BIOFILM; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG POTENCY; DRUG STRUCTURE; GENE EXPRESSION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PLATING MEDIUM; RADIOACTIVITY; STRUCTURE ANALYSIS; DRUG EFFECT; METABOLISM; MICROBIOLOGICAL EXAMINATION; PENICILLIN RESISTANCE; PHYSIOLOGY; PROTEIN BINDING; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BIOFILMS; CARRIER PROTEINS; CEPHALOSPORINS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; PENICILLIN-BINDING PROTEINS; PROTEIN BINDING; STAPHYLOCOCCUS AUREUS;

EID: 17444403247     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dki003     Document Type: Article

References (10)

1. Fujimura, T., Yamano, Y., Yoshida, I. et al. (2003). In vitro activity of S-3578, a new broad-spectrum cephalosporin active against methicillin-resistant staphylococci. Antimicrobial Agents and Chemotherapy 47, 923-31.
2. Malouin, F., Blais, J., Chamberland, S. et al. (2003). RWJ-54428 (MC-02,479), a new cephalosporin with high affinity for penicillin-binding proteins, including PBP 2a, and stability to staphylococcal β-lactamases. Antimicrobial Agents and Chemotherapy 47, 658-64.
3. Huang, V., Brown, W. J. & Rybak, M. J. (2004). In vitro activities of a novel cephalosporin, CB-181963 (CAB-175), against methicillin-susceptible or -resistant Staphylococcus aureus and glycopeptide-intermediate susceptible staphylococci. Antimicrobial Agents and Chemotherapy 48, 2719-23.
4. Haas, D. W. & Kaiser, A. B. (1994). Antimicrobial prophylaxis of infections associated with foreign bodies. In Infections Associated with Indwelling Medical Devices, 2nd edn (Bisno, A. L. & Waldvogel, F. A. Eds), pp. 375-88. ASM Press, Washington DC, USA.
5. Report of the Working Party on Antibiotic Sensitivity Testing of the British Society for Antimicrobial Chemotherapy. (1991). A guide to sensitivity testing. Journal of Antimicrobial Chemotherapy 27 Suppl. D, 1-50.
6. Ceri, H., Olson, M. E., Stremick, C. et al. (1999). The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. Journal of Clinical Microbiology 37, 1771-6.
7. McDonald, P. J., Craig, W. A. & Kunin, C. M. (1977). Persistent effect of antibiotics on Staphylococcus aureus after exposure for limited periods of time. Journal of Infectious Diseases 135, 217-23.
8. O'Neill, A. J., Cove, J. H. & Chopra, I. (2001). Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus. Journal of Antimicrobial Chemotherapy 47, 647-50.
9. Komatsuzawa, H., Choi, G. H., Ohta, K. et al. (1999). Cloning and characterization of a gene, pbpF, encoding a new penicillin-binding protein, PBP2B, in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 43, 1578-83.
10. Lu, W. P., Sun, Y. P., Bauer, M. D. et al. (1999). Penicillin-binding protein 2a from methicillin-resistant Staphylococcus aureus: kinetic characterization of its interactions with β-lactams using electrospray mass spectrometry. Biochemistry 38, 6537-46.